RxDoctor Payments DataLook up a doctor →

William Shomali, MD

Hematology · Stanford, CANPI 1407113871

Payments from drug & device makers

$1,989,666in general payments, 2019–2025

Across 682 payments — averaging $2917.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$1.6M
  • Blueprint Medicines Corporation$404K
  • Sanofi US Services Inc.$31K
  • Bristol Myers Squibb$22

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,989,666 in reported general payments places this provider in the 75th percentile of 178 hematology providers in California.

See all hematology providers in California

Medicare billing

Part B allowed, 2024
$113,752
Medicare patients
241
Services billed
812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →